Literature DB >> 32991718

Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study.

Jose F Camargo1, Rick Y Lin2, Yoichiro Natori1, Anthony D Anderson3, Maritza C Alencar4, Trent P Wang4, Michele I Morris1, Krishna V Komanduri4.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32991718      PMCID： PMC7556121          DOI： 10.1182/bloodadvances.2020002269

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  12 in total

1.  Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.

Authors:  Adriana Bastidas; Javier de la Serna; Mohamed El Idrissi; Lidia Oostvogels; Philippe Quittet; Javier López-Jiménez; Filiz Vural; David Pohlreich; Tsila Zuckerman; Nicolas C Issa; Gianluca Gaidano; Je-Jung Lee; Sunil Abhyankar; Carlos Solano; Jaime Perez de Oteyza; Michael J Satlin; Stefan Schwartz; Magda Campins; Alberto Rocci; Carlos Vallejo Llamas; Dong-Gun Lee; Sen Mui Tan; Anna M Johnston; Andrew Grigg; Michael J Boeckh; Laura Campora; Marta Lopez-Fauqued; Thomas C Heineman; Edward A Stadtmauer; Keith M Sullivan
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

2.  Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.

Authors:  Michael Boeckh; Hyung W Kim; Mary E D Flowers; Joel D Meyers; Raleigh A Bowden
Journal:  Blood       Date:  2005-11-10       Impact factor: 22.113

3.  A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.

Authors:  Edward A Stadtmauer; Keith M Sullivan; Francisco M Marty; Sanjeet S Dadwal; Genovefa A Papanicolaou; Thomas C Shea; Sherif B Mossad; Charalambos Andreadis; Jo-Anne H Young; Francis K Buadi; Mohamed El Idrissi; Thomas C Heineman; Elchonon M Berkowitz
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 4.  Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5).

Authors:  Vincent Mallet; Florian van Bömmel; Christopher Doerig; Sven Pischke; Olivier Hermine; Anna Locasciulli; Catherine Cordonnier; Thomas Berg; Darius Moradpour; Heiner Wedemeyer; Per Ljungman
Journal:  Lancet Infect Dis       Date:  2016-04-18       Impact factor: 25.071

5.  Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.

Authors:  Alemnew F Dagnew; Osman Ilhan; Won-Sik Lee; Dariusz Woszczyk; Jae-Yong Kwak; Stella Bowcock; Sang Kyun Sohn; Gabriela Rodriguez Macías; Tzeon-Jye Chiou; Dimas Quiel; Mickael Aoun; Maria Belen Navarro Matilla; Javier de la Serna; Samuel Milliken; John Murphy; Shelly A McNeil; Bruno Salaun; Emmanuel Di Paolo; Laura Campora; Marta López-Fauqued; Mohamed El Idrissi; Anne Schuind; Thomas C Heineman; Peter Van den Steen; Lidia Oostvogels
Journal:  Lancet Infect Dis       Date:  2019-08-06       Impact factor: 25.071

6.  Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo.

Authors:  Jennifer Moffat; Chengjun Mo; Jason J Cheng; Marvin Sommer; Leigh Zerboni; Shaye Stamatis; Ann M Arvin
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.

Authors:  C Heining; A Spyridonidis; E Bernhardt; J Schulte-Mönting; D Behringer; C Grüllich; A Jakob; H Bertz; J Finke
Journal:  Bone Marrow Transplant       Date:  2007-03-26       Impact factor: 5.483

8.  High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis.

Authors:  Elisabetta Xue; Hu Xie; Wendy M Leisenring; Louise E Kimball; Sonia Goyal; Lisa Chung; Rachel Blazevic; Byron Maltez; Anna Edwards; Ann E Dahlberg; Rachel B Salit; Colleen Delaney; Steven A Pergam; Michael Boeckh; Filippo Milano; Joshua A Hill
Journal:  Clin Infect Dis       Date:  2021-04-26       Impact factor: 9.079

9.  Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo-controlled study.

Authors:  Elchonon M Berkowitz; Graeme Moyle; Hans-Jürgen Stellbrink; Dirk Schürmann; Stephen Kegg; Matthias Stoll; Mohamed El Idrissi; Lidia Oostvogels; Thomas C Heineman
Journal:  J Infect Dis       Date:  2014-11-03       Impact factor: 5.226

10.  Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.

Authors:  Peter Vink; Ignacio Delgado Mingorance; Constanza Maximiano Alonso; Belen Rubio-Viqueira; Kyung Hae Jung; Juan Francisco Rodriguez Moreno; Enrique Grande; David Marrupe Gonzalez; Sarah Lowndes; Javier Puente; Hartmut Kristeleit; David Farrugia; Shelly A McNeil; Laura Campora; Emmanuel Di Paolo; Mohamed El Idrissi; Olivier Godeaux; Marta López-Fauqued; Bruno Salaun; Thomas C Heineman; Lidia Oostvogels
Journal:  Cancer       Date:  2019-02-01       Impact factor: 6.860
View more
  7 in total

1.  Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation.

Authors:  Emily Baumrin; Natalie E Izaguirre; Bruce Bausk; Monica M Feeley; Camden P Bay; Qiheng Yang; Vincent T Ho; Lindsey R Baden; Nicolas C Issa
Journal:  Blood Adv       Date:  2021-03-23

Review 2.  Infectious complications and vaccines.

Authors:  Per Ljungman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 3.  Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.

Authors:  Helen E Heslop; Edward A Stadtmauer; John E Levine; Karen K Ballen; Yi-Bin Chen; Amy E DeZern; Mary Eapen; Mehdi Hamadani; Betty K Hamilton; Parameswaran Hari; Richard J Jones; Brent R Logan; Leslie S Kean; Eric S Leifer; Frederick L Locke; Richard T Maziarz; Eneida R Nemecek; Marcelo Pasquini; Rachel Phelan; Marcie L Riches; Bronwen E Shaw; Mark C Walters; Amy Foley; Steven M Devine; Mary M Horowitz
Journal:  Transplant Cell Ther       Date:  2021-08-27

Review 4.  Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients.

Authors:  Madeleine R Heldman; Kaja M Aagaard; Joshua A Hill
Journal:  Clin Microbiol Infect       Date:  2022-02-10       Impact factor: 13.310

5.  Cellular Immune Response after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Authors:  Michael Koldehoff; Peter A Horn; Monika Lindemann
Journal:  Vaccines (Basel)       Date:  2022-05-20

6.  Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.

Authors:  Edward A Stadtmauer; Keith M Sullivan; Mohamed El Idrissi; Bruno Salaun; Aránzazu Alonso Alonso; Charalambos Andreadis; Veli-Jukka Anttila; Adrian Jc Bloor; Raewyn Broady; Claudia Cellini; Antonio Cuneo; Alemnew F Dagnew; Emmanuel Di Paolo; HyeonSeok Eom; Ana Pilar González-Rodríguez; Andrew Grigg; Andreas Guenther; Thomas C Heineman; Isidro Jarque; Jae-Yong Kwak; Alessandro Lucchesi; Lidia Oostvogels; Marta Polo Zarzuela; Anne E Schuind; Thomas C Shea; Ulla Marjatta Sinisalo; Filiz Vural; Lucrecia Yáñez San Segundo; Pierre Zachée; Adriana Bastidas
Journal:  Hum Vaccin Immunother       Date:  2021-08-18       Impact factor: 3.452

Review 7.  Vaccine Responses in Adult Hematopoietic Stem Cell Transplant Recipients: A Comprehensive Review.

Authors:  Michelle Janssen; Anke Bruns; Jürgen Kuball; Reinier Raijmakers; Debbie van Baarle
Journal:  Cancers (Basel)       Date:  2021-12-06       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.